Fact 7: The Genetic Angle – Impact of DNA Mutations
Modern medicine’s understanding of cancer has evolved, moving beyond mere cellular anomalies to the genetic underpinnings that drive these changes. In the world of HCC prognosis, DNA mutations have taken center stage, offering both challenges and opportunities.
Certain genetic mutations have been linked to an increased risk of developing HCC. For instance, mutations in the TERT or TP53 genes are often associated with a higher probability of HCC. Recognizing these mutations early can lead to more proactive monitoring and possibly earlier interventions.
On the treatment front, these genetic insights open doors to targeted therapies. Drugs designed to act against specific mutations can offer personalized treatment plans that might prove more effective than traditional, broad-spectrum chemotherapies.(7)
